Mark Howard Snyder - Jan 3, 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF LEGAL OFFICER
Signature
/s/ James Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Jan 3, 2025
Transactions value $
-$204,757
Form type
4
Date filed
1/6/2025, 05:12 PM
Previous filing
Jun 14, 2024
Next filing
Feb 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +7.61K +65.16% $0.00 19.3K Jan 3, 2025 Direct
transaction HALO Common Stock Tax liability -$205K -4.29K -22.23% $47.74 15K Jan 3, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -7.61K -50% $0.00 7.61K Jan 3, 2025 Common Stock 7.61K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 4,289 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.